The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thromboembolism

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr class="thead"><td class="align_left">Groups</td><td class="align_center">Case</td><td class="align_center">CR</td><td class="align_center">PR</td><td class="align_center">NC</td><td class="align_center">PD</td><td class="align_center">CR+PR</td></tr><tr><td class="thead-hr" colspan="7"><hr/></td></tr><tr><td class="align_left">CCRT</td><td class="align_center">30</td><td class="align_center">1</td><td class="align_center">17</td><td class="align_center">12</td><td class="align_center">0</td><td class="align_center">60.00%</td></tr><tr><td class="align_left">CCRT+LWMH</td><td class="align_center">30</td><td class="align_center">7</td><td class="align_center">18</td><td class="align_center">5</td><td class="align_center">0</td><td class="align_center">83.33%</td></tr><tr><td class="align_left">Total</td><td class="align_center">60</td><td class="align_center">8</td><td class="align_center">35</td><td class="align_center">17</td><td class="align_center">0</td><td class="align_left"></td></tr><tr class="table-tr"><td colspan="7"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of short-term efficacy.</div>

BioMed Research International

tab2

Table 2

Table 2: The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thromboembolism 

Table 2 | The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thromboembolism 